Q1 2020 13F Holders as of 31 Mar 2020
-
Type / Class
-
Equity / CL B
-
Number of holders
-
6
-
Total 13F shares, excl. options
-
16,266
-
Shares change
-
-2,255
-
Total reported value, excl. options
-
$5,703,000
-
Value change
-
-$831,233
-
Number of buys
-
1
-
Number of sells
-
-4
-
Price
-
$351.02
Significant Holders of BIO RAD LABS INC - CL B (BIOB) as of Q1 2020
9 filings reported holding BIOB - BIO RAD LABS INC - CL B as of Q1 2020.
BIO RAD LABS INC - CL B (BIOB) has 6 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 16,266 shares
.
Largest 9 shareholders include CSS LLC/IL (13,588 shares), RENAISSANCE TECHNOLOGIES LLC (2,000 shares), MORGAN STANLEY (522 shares), UBS Group AG (95 shares), WELLS FARGO & COMPANY/MN (56 shares), BANK OF AMERICA CORP /DE/ (5 shares), Copperwynd Financial, LLC (0 shares), GAMCO INVESTORS, INC. ET AL (0 shares), and Rehmann Capital Advisory Group (0 shares).
This table shows the top 6 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.